Substance abuse


According to the WHO ATLAS globally 3.5%–5.7% of 15–64 year olds reportedly use illicit drugs. Between 10% and 15% of these people are estimated to develop dependence or a pattern of harmful use. In the Eastern Mediterranean Region prevalence of drug use disorders is estimated to be 3500 per 100 000 population and that of injecting drug use is 172 per 100 000 accounting for a loss of 4 disability-adjusted life years (DALYs) and 9 deaths per 1000 population, compared with the loss of 2 DALYs and 4 deaths per 1000 population globally.

The WHO mental health and substance abuse programme provides technical support to Member States to develop evidence-informed policies, plans and legislation; promote the most effective prevention, care and treatment services for substance use disorders, including long-term maintenance programmes which replace opioids with opioid-like (or agonist) substances, and integrate these services into primary care health systems.

 

 

Information resources

Print PDF

Recent publications

Atlas on substance use [2010]: resources for the prevention and treatment of substance use disorders [pdf 3.55 MB]

Thumbnail of Guideline for psychosocially assisted pharmacological treatmentGuidelines for the psychosocially assisted pharmacological treatment of opioid dependence [pdf 1.08 MB]

mhGAP intervention guide for mental, neurological and substance use disorders in non-specialized health settings: mental health Gap Action Programme [mhGAP] [pdf 1.89 MB]

Thumbnail of Self-help strategies for cutting down or stopping substance use: a guidecoholSelf-help strategies for cutting down or stopping substance use: a guide [pdf 2.23 MB]

Thumbnail of The Alcohol, Smoking and Substance involvement Screening Test (ASSIST): manual for use in primary careThe Alcohol, Smoking and Substance involvement Screening Test (ASSIST): manual for use in primary care [pdf 1.50 MB]

Thumbnail of The ASSIST-linked brief intervention for hazardous and harmful substance use: a manual for use in primary careThe ASSIST-linked brief intervention for hazardous and harmful substance use: a manual for use in primary care[pdf 1.12 MB]

Policy documents

mhGAP: Mental Health Gap Action Programme: scaling up care for mental, neurological and substance use disorders [pdf 804 KB] | Arabic [pdf 804 KB]

Strategy for mental health and substance abuse in the Eastern Mediterranean Region 2012–2016 [pdf 52 KB] | Arabic [pdf 52 KB] | French [pdf 52 KB]

Technical paper Maternal, child and adolescent mental health: challenges and strategic directions 2010–2015 [pdf 88 KB] | Arabic [pdf 88 KB] l French [pdf 88 KB]  

Links

Cochrane Drugs and Alcohol Group

European Monitoring Centre for Drugs and Drug Addiction

International network on Brief Intervention for Alcohol Problems

International Statistical Classification of Diseases (ICD-10)/Mental and behavioural disorders due to psychoactive substance use

Middle East & North Africa Harm Reduction (MENAHRA)

Pompidou Group/Combating drug use and drug trafficking

The Royal College of Psychiatrists/Alcohol and drugs